Prevalence and predictors of microalbuminuria in Jamaican children with sickle cell disease

Archives of Disease in Childhood

Volumn 96, Issue 12, 2011, Pages 1135-1139

  King, Lesley ^a   MooSang, Michelle ^a   Miller, Maolynne ^b   Reid, Marvin ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b UNIVERSITY HOSPITAL OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

ALBUMIN BLOOD LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; JAMAICA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROALBUMINURIA; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SICKLE CELL ANEMIA;

ADOLESCENT; ALBUMINURIA; ANEMIA, SICKLE CELL; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; CREATININE; EPIDEMIOLOGIC METHODS; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HUMANS; JAMAICA; MALE;

EID: 81255134056     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2011-300628     Document Type: Article

References (34)

1. Saborio P, Scheinman JI. Sickle cell nephropathy. J Am Soc Nephrol 1999;10:187-92. (Pubitemid 29034960)
2. Morgan AG, Shah DJ, Williams W. Renal pathology in adults over 40 with sickle-cell disease. West Indian Med J 1987;36:241-50.
3. Powars DR, Elliott-Mills DD, Chan L, et al. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med 1991;115:614-20.
4. Aoki RY, Saad ST. Microalbuminuria in sickle cell disease. Braz J Med Biol Res 1990;23:1103-6.
5. Dharnidharka VR, Dabbagh S, Atiyeh B, et al. Prevalence of microalbuminuria in children with sickle cell disease. Pediatr Nephrol 1998;12:475-8. (Pubitemid 28396035)
6. McBurney PG, Hanevold CD, Hernandez CM, et al. Risk factors for microalbuminuria in children with sickle cell anemia. J Pediatr Hematol Oncol 2002;24:473-7.
7. McKie KT, Hanevold CD, Hernandez C, et al. Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease. J Pediatr Hematol Oncol 2007;29:140-4. (Pubitemid 46673398)
8. Marsenic O, Couloures KG, Wiley JM. Proteinuria in children with sickle cell disease. Nephrol Dial Transplant 2008;23:715-20. (Pubitemid 351767657)
9. Datta V, Ayengar JR, Karpate S, et al. Microalbuminuria as a predictor of early glomerular injury in children with sickle cell disease. Indian J Pediatr 2003;70:307-9. (Pubitemid 36617270)
10. King L, Fraser R, Forbes M, et al. Newborn sickle cell disease screening: the Jamaican experience (1995-2006). J Med Screen 2007;14:117-22. (Pubitemid 47511120)
11. Cole TJ, Freeman JV, Preece MA. British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Stat Med 1998;17:407-29. (Pubitemid 28057006)
12. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-266.
13. Morgenstern BZ, Butani L, Wollan P, et al. Validity of protein-osmolality versus protein-creatinine ratios in the estimation of quantitative proteinuria from random samples of urine in children. Am J Kidney Dis 2003;41:760-6. (Pubitemid 36396743)
14. Lambers Heerspink HJ, Gansevoort RT, Brenner BM, et al. Comparison of different measures of urinary protein excretion for prediction of renal events. J Am Soc Nephrol 2010;21:1355-60.
15. Cole TJ. Sympercents: symmetric percentage differences on the 100 log(e) scale simplify the presentation of log transformed data. Stat Med 2000;19:3109-25.
16. Scott Long J. Limited outcomes: the tobit model. In: Regression Models for Categorical and Limited Dependent Variables. Series editor: Richard Burk. SAGE Publications, London; 1997:187-216.
17. Helsel DR. More than obvious: better methods for interpreting nondetect data. Environ Sci Technol 2005;39:419A-23A. (Pubitemid 41476571)
18. Han C, Kronmal R. Box-Cox transformation of left-censored data with application to the analysis of coronary artery calcification and pharmacokinetic data. Stat Med 2004;23:3671-9. (Pubitemid 39549570)
19. Alvarez O, Zilleruelo G, Wright D, et al. Serum cystatin C levels in children with sickle cell disease. Pediatr Nephrol 2006;21:533-7.
20. Ware RE, Rees RC, Sarnaik SA, et al. Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial. J Pediatr 2010;156:66-70.e1.
21. Singhal A, Parker S, Linsell L, et al. Energy intake and resting metabolic rate in preschool Jamaican children with homozygous sickle cell disease. Am J Clin Nutr 2002;75:1093-7. (Pubitemid 34547540)
22. Miller TL. Malnutrition: metabolic changes in children, comparisons with adults. J Nutr 1996;126:2623-31S.
23. Roubenoff R, Roubenoff RA, Cannon JG, et al. Rheumatoid cachexia: cytokinedriven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994;93:2379-86. (Pubitemid 24177149)
24. Hibbert JM, Hsu LL, Bhathena SJ, et al. Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease. Exp Biol Med (Maywood) 2005;230:68-74. (Pubitemid 40041074)
25. Bainbridge R, Higgs DR, Maude GH, et al. Clinical presentation of homozygous sickle cell disease. J Pediatr 1985;106:881-5. (Pubitemid 15006629)
26. Miller ST, Sleeper LA, Pegelow CH, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000;342:83-9. (Pubitemid 30036599)
27. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 2007;21:37-47. (Pubitemid 46110926)
28. Kato GJ, McGowan V, Machado RF, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006;107:2279-85. (Pubitemid 43345545)
29. Haymann JP, Stankovic K, Levy P, et al. Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature. Clin J Am Soc Nephrol 2010;5:756-61.
30. Gurkan S, Scarponi KJ, Hotchkiss H, et al. Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia. Pediatr Nephrol 2010;25:2123-7.
31. Brittain JE, Parise LV. Cytokines and plasma factors in sickle cell disease. Curr Opin Hematol 2007;14:438-43. (Pubitemid 47457633)
32. Faul C, Donnelly M, Merscher-Gomez S, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008;14:931-8.
33. Hogg RJ, Furth S, Lemley KV, et al. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 2003;111:1416-21. (Pubitemid 36682280)
34. Fitzhugh CD, Wigfall DR, Ware RE. Enalapril and hydroxyurea therapy for children with sickle nephropathy. Pediatr Blood Cancer 2005;45:982-5. (Pubitemid 41552170)